INNVInnovAge Holding Corp.

$11.04

Price

$11.04+237%1Y
1M-1.3%1Y+237%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Top tier
10/10
Value72
Quality70
Momentum91
Growth64
Strongest Momentum, weakest Growth · ranked vs Healthcare peers. The five questions below judge the company on its own terms.
What they do

InnovAge is the leading healthcare delivery platform by number of participants focused on providing all-inclusive, capitated care to high-cost, seniors, many of whom are dual-eligible. Our programs are designed to address two of the most pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of our participant-centered care delivery approach is to improve the quality of care our participants receive, while keeping them in their homes for as long as safely possible and reducing over-utilization of high-cost care settings such as hospitals and nursing homes.

In the company’s own words · 10-K filed Sep 9, 2025 · SEC EDGAR

P/E (TTM)-
Market Cap$1.22B
1Y Return+237%
5Y Return-34%

Business segments

Q1 2026 · $251.9M

The company’s own SEC segment disclosure.

  • Capitation$251.5M100%
  • Other Service$441.0K0%

InnovAge Holding Corp. (INNV) reported revenue of $252M in Q3 2026 (quarter ended March 31, 2026), up 15% from the same quarter a year earlier. That came with a gross margin of 24% and net loss of $29M. For the full year FY2025, revenue was $854M (+12% year on year) and net income −$30M. Its largest product in 2026-Q1 was Capitation at $252M, 100% of the disclosed total, just ahead of Other Service at 0.2%.

Raw charts

11 series · TTM

As reported to the SEC, without any scoring.